Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis
Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of...
Saved in:
Published in: | Urology annals Vol. 12; no. 3; pp. 241 - 247 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
India
Wolters Kluwer India Pvt. Ltd
01-07-2020
Medknow Publications and Media Pvt. Ltd Medknow Publications & Media Pvt. Ltd Wolters Kluwer - Medknow Wolters Kluwer Medknow Publications |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia.
Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716).
Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses.
Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime. |
---|---|
AbstractList | BACKGROUNDPersistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. MATERIALS AND METHODSA systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). RESULTSNineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. CONCLUSIONThe overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime. Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%–76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%–18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%–15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%–41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime. Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime. Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1 year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA ( = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime. |
Audience | Academic |
Author | Leeaphorn, Napat Bathini, Tarun Cheungpasitporn, Wisit Boonpheng, Boonphiphop Watthanasuntorn, Kanramon Aeddula, Narothama Lertjitbanjong, Ploypin Chesdachai, Supavit Kaewput, Wisit Torres-Ortiz, Aldo Khoury, Nadeen Bruminhent, Jackrapong Thongprayoon, Charat Mao, Michael |
AuthorAffiliation | 7 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA 6 Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke's Health System, Kansas City, Missouri, USA 1 Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan, USA 8 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, USA 2 Department of Internal Medicine, University of Arizona, Tucson, Arizona, USA 10 Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 5 Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA 3 Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana, USA 11 Department of |
AuthorAffiliation_xml | – name: 6 Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke's Health System, Kansas City, Missouri, USA – name: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, USA – name: 1 Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan, USA – name: 3 Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana, USA – name: 8 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA – name: 4 Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee, USA – name: 7 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA – name: 9 Department of Military and Community Medicine, Phramongkutklao College of Medicine, Mahidol University, Bangkok, Thailand – name: 5 Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA – name: 11 Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA – name: 2 Department of Internal Medicine, University of Arizona, Tucson, Arizona, USA – name: 10 Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand |
Author_xml | – sequence: 1 givenname: Charat surname: Thongprayoon fullname: Thongprayoon, Charat organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester – sequence: 2 givenname: Nadeen surname: Khoury fullname: Khoury, Nadeen organization: Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan – sequence: 3 givenname: Tarun surname: Bathini fullname: Bathini, Tarun organization: Department of Internal Medicine, University of Arizona, Tucson, Arizona – sequence: 4 givenname: Narothama surname: Aeddula fullname: Aeddula, Narothama organization: Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana – sequence: 5 givenname: Boonphiphop surname: Boonpheng fullname: Boonpheng, Boonphiphop organization: Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee – sequence: 6 givenname: Ploypin surname: Lertjitbanjong fullname: Lertjitbanjong, Ploypin organization: Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York – sequence: 7 givenname: Kanramon surname: Watthanasuntorn fullname: Watthanasuntorn, Kanramon organization: Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York – sequence: 8 givenname: Napat surname: Leeaphorn fullname: Leeaphorn, Napat organization: Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke′s Health System, Kansas City, Missouri – sequence: 9 givenname: Supavit surname: Chesdachai fullname: Chesdachai, Supavit organization: Department of Medicine, University of Minnesota, Minneapolis, Minnesota – sequence: 10 givenname: Aldo surname: Torres-Ortiz fullname: Torres-Ortiz, Aldo organization: Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi – sequence: 11 givenname: Wisit surname: Kaewput fullname: Kaewput, Wisit organization: Department of Military and Community Medicine, Phramongkutklao College of Medicine, Mahidol University, Bangkok – sequence: 12 givenname: Jackrapong surname: Bruminhent fullname: Bruminhent, Jackrapong organization: Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok – sequence: 13 givenname: Michael surname: Mao fullname: Mao, Michael organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida – sequence: 14 givenname: Wisit surname: Cheungpasitporn fullname: Cheungpasitporn, Wisit organization: Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33100749$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ktuLEzEYxQdZcS_65LsMCCJIa-4zERTqsurCgi_2UUImlzbdmWRMZlr635va7bqVRUJISH7fSb7DOS9OfPCmKF5CMCUQ4Pfz2XQ-EzUXkD8pzgCvyKSqMTk57CvOTovzlFYAMMYAeVacYgwBqAg_K35e9U6bzoU2LLZlsGUv4zqsXRxT-RnyUnqdZwZkKbvgF-Wt095syyFKn_pW-qGMRrneGT-kD-Ws7MwgJ9LLdptcel48tbJN5sXdelHMv1z9uPw2ufn-9fpydjNRjNIw0YQpBAzUGqFKAyMriAAzvKJQWaxqUlnLFG5swxDUDYSWQ1UDoDCXlawpviiu97o6yJXoo-tk3IognfhzEOJCyDg41RphsVbQIEYtBUTTinOKGwVribjGRjZZ69Neqx-bzmiVG4uyPRI9vvFuKRZhLSpKGKhAFnh7JxDDr9GkQXQuKdNms0wYk0CEEgI44jv09T_oKowxm5cpihEnsAbwvxRBNPeBAPpLLWRu03kb8u_U7mkxYxgAhGqEMzV9hMpjFwKVg2VdPj8qePOgYGlkOyxTaMfBBZ-OwXd7UMWQUjT23jIIxC6oIqf0ENRMv3ro8j17SGYGPu6BTWgHE9NtO25MFJm99WHzmGY2A4pDnPFvufn3cA |
CitedBy_id | crossref_primary_10_3390_ijms24119147 crossref_primary_10_3389_fmed_2023_1170100 crossref_primary_10_1007_s00277_022_04831_w crossref_primary_10_1016_j_meegid_2022_105307 crossref_primary_10_1093_ofid_ofad079 crossref_primary_10_1016_j_clim_2023_109782 crossref_primary_10_1007_s00467_024_06378_6 crossref_primary_10_2147_IDR_S321936 crossref_primary_10_3389_fmed_2023_1195419 |
ContentType | Journal Article |
Copyright | Copyright: © 2020 Urology Annals. COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. 2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright: © 2020 Urology Annals 2020 |
Copyright_xml | – notice: Copyright: © 2020 Urology Annals. – notice: COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd. – notice: 2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright: © 2020 Urology Annals 2020 |
DBID | NPM AAYXX CITATION K9. 3V. 7X7 7XB 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH M0S M2O MBDVC PADUT PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.4103/UA.UA_89_19 |
DatabaseName | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Health & Medical Collection (Alumni Edition) ProQuest Research Library Research Library (Corporate) Research Library China Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Research Library (Alumni Edition) Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library Research Library China ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database ProQuest Health & Medical Complete (Alumni) PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 0974-7834 |
EndPage | 247 |
ExternalDocumentID | oai_doaj_org_article_f3dc1e265f504d579953bc18a29d3eab A630022823 10_4103_UA_UA_89_19 33100749 10.4103/UA.UA_89_19_241_Epidemio |
Genre | Journal Article |
GroupedDBID | - 29Q 2WC 3V. 53G 5VS 7X7 8FI 8G5 ABDBF ABPTK ABUWG ACGFS ADACO ADBBV AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBAFP BCNDV BENPR BPHCQ BVXVI DIK DWQXO E3Z EBD EBS EJD ESX F5P FYUFA GROUPED_DOAJ GUQSH GX1 HYE IAO IEA IHR IHW INH INR ITC KQ8 M2O MBDVC M~E O5R O5S OBODZ OK1 P2P PIMPY PQEST PQQKQ PQUKI PRINS PROAC RIG RMW RNS RPM TUS W3E --- 8FJ ABXLX ADRAZ ALIPV AOIJS CCPQU EOJEC GNUQQ H13 HMCUK IL9 IPNFZ M48 NPM OVD PADUT PGMZT TEORI TR2 UKHRP ~8M AAYXX CITATION K9. 7XB 8FK Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c655o-d46c20e1dd227d0ea71206e9751cf3c847ff6c3bfb621db11f91c800c39a7a853 |
IEDL.DBID | RPM |
ISSN | 0974-7796 |
IngestDate | Tue Oct 22 15:05:23 EDT 2024 Tue Sep 17 20:52:28 EDT 2024 Fri Aug 16 23:33:34 EDT 2024 Tue Nov 19 05:52:49 EST 2024 Thu Oct 10 21:18:06 EDT 2024 Tue Nov 19 21:09:46 EST 2024 Tue Nov 12 23:05:22 EST 2024 Tue Aug 20 22:10:48 EDT 2024 Fri Aug 23 00:32:34 EDT 2024 Sat Sep 28 08:20:24 EDT 2024 Tue Jan 05 18:26:27 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | meta-analysis systematic reviews renal transplantation parvovirus B19 Kidney transplantation |
Language | English |
License | http://creativecommons.org/licenses/by-nc-sa/4.0 Copyright: © 2020 Urology Annals. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c655o-d46c20e1dd227d0ea71206e9751cf3c847ff6c3bfb621db11f91c800c39a7a853 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546070/ |
PMID | 33100749 |
PQID | 2532941801 |
PQPubID | 226454 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f3dc1e265f504d579953bc18a29d3eab pubmedcentral_primary_oai_pubmedcentral_nih_gov_7546070 proquest_miscellaneous_2454409290 proquest_journals_2532941801 proquest_journals_2425504202 gale_infotracmisc_A630022823 gale_infotracacademiconefile_A630022823 gale_healthsolutions_A630022823 crossref_primary_10_4103_UA_UA_89_19 pubmed_primary_33100749 wolterskluwer_medknow_10_4103_UA_UA_89_19_241_Epidemio |
ProviderPackageCode | W3E RMW |
PublicationCentury | 2000 |
PublicationDate | 20200701 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 7 year: 2020 text: 20200701 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | India |
PublicationPlace_xml | – name: India – name: Mumbai |
PublicationTitle | Urology annals |
PublicationTitleAlternate | Urol Ann |
PublicationYear | 2020 |
Publisher | Wolters Kluwer India Pvt. Ltd Medknow Publications and Media Pvt. Ltd Medknow Publications & Media Pvt. Ltd Wolters Kluwer - Medknow Wolters Kluwer Medknow Publications |
Publisher_xml | – name: Wolters Kluwer India Pvt. Ltd – name: Medknow Publications and Media Pvt. Ltd – name: Medknow Publications & Media Pvt. Ltd – name: Wolters Kluwer - Medknow – name: Wolters Kluwer Medknow Publications |
References | Carraturo (key-10.4103/0974-7796.286327-21) 2012 Egbuna (key-10.4103/0974-7796.286327-17) 2006 DerSimonian (key-10.4103/0974-7796.286327-31) 1986 Khameneh (key-10.4103/0974-7796.286327-23) 2014 Parsyan (key-10.4103/0974-7796.286327-39) 2007 Anderson (key-10.4103/0974-7796.286327-3) 1986 Cavallo (key-10.4103/0974-7796.286327-14) 2003 Porignaux (key-10.4103/0974-7796.286327-22) 2013 Bertoni (key-10.4103/0974-7796.286327-10) 1997 Čapenko (key-10.4103/0974-7796.286327-20) 2012 Zolnourian (key-10.4103/0974-7796.286327-12) 2000 Ardalan (key-10.4103/0974-7796.286327-18) 2008 Higgins (key-10.4103/0974-7796.286327-32) 2003 Vanrenterghem (key-10.4103/0974-7796.286327-35) 2004 Jordan (key-10.4103/0974-7796.286327-7) 1998 Ardalan (key-10.4103/0974-7796.286327-36) 2008 Waldman (key-10.4103/0974-7796.286327-8) 2007 Easterbrook (key-10.4103/0974-7796.286327-33) 1991 Fishman (key-10.4103/0974-7796.286327-37) 2017 Pambrun (key-10.4103/0974-7796.286327-24) 2014 Cossart (key-10.4103/0974-7796.286327-1) 1975 Razonable (key-10.4103/0974-7796.286327-4) 2016 Barsoum (key-10.4103/0974-7796.286327-29) 2002 Baek (key-10.4103/0974-7796.286327-26) 2017 Moher (key-10.4103/0974-7796.286327-30) 2009 Pattison (key-10.4103/0974-7796.286327-6) 1981 Malyszko (key-10.4103/0974-7796.286327-13) 2002 Woolf (key-10.4103/0974-7796.286327-9) 1989 Plentz (key-10.4103/0974-7796.286327-5) 2013 Gallinella (key-10.4103/0974-7796.286327-11) 1999 Eid (key-10.4103/0974-7796.286327-16) 2006 Krishnan (key-10.4103/0974-7796.286327-25) 2015 Bertoni (key-10.4103/0974-7796.286327-34) 1997 Jordan (key-10.4103/0974-7796.286327-28) 2011 Eid (key-10.4103/0974-7796.286327-2) 2013 Cheungpasitporn (key-10.4103/0974-7796.286327-38) 2018 Xiao (key-10.4103/0974-7796.286327-27) 2013 Ki (key-10.4103/0974-7796.286327-15) 2005 Park (key-10.4103/0974-7796.286327-19) 2009 |
References_xml | – start-page: 856 volume-title: Infection in organ transplantation year: 2017 ident: key-10.4103/0974-7796.286327-37 publication-title: Am J Transplant contributor: fullname: Fishman – start-page: 1153 volume-title: Clinical manifestations of human parvovirus B19 in adults year: 1989 ident: key-10.4103/0974-7796.286327-9 publication-title: Arch Intern Med contributor: fullname: Woolf – start-page: 428 volume-title: Not the usual viral suspects: Parvovirus B19, West Nile virus, and human T-cell lymphotrophic virus infections after kidney transplantation year: 2016 ident: key-10.4103/0974-7796.286327-4 publication-title: Semin Nephrol contributor: fullname: Razonable – start-page: 97 volume-title: Human parvovirus B19: Prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients year: 1998 ident: key-10.4103/0974-7796.286327-7 publication-title: Vox Sang contributor: fullname: Jordan – start-page: 225 volume-title: A cluster of parvovirus B19 infections in renal transplant recipients: A prospective case series and review of the literature year: 2006 ident: key-10.4103/0974-7796.286327-17 publication-title: Am J Transplant contributor: fullname: Egbuna – start-page: V54 volume-title: Anaemia after renal transplantation year: 2004 ident: key-10.4103/0974-7796.286327-35 publication-title: Nephrol Dial Transplant contributor: fullname: Vanrenterghem – start-page: e13194 volume-title: De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection year: 2018 ident: key-10.4103/0974-7796.286327-38 publication-title: Clin Transplant contributor: fullname: Cheungpasitporn – start-page: e12754 volume-title: Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients year: 2017 ident: key-10.4103/0974-7796.286327-26 publication-title: Transpl Infect Dis contributor: fullname: Baek – start-page: 557 volume-title: Measuring in consistency in meta-analyses year: 2003 ident: key-10.4103/0974-7796.286327-32 publication-title: BMJ contributor: fullname: Higgins – start-page: 811 volume-title: Occurrence and clinical role of active parvovirus B19 infection in transplant recipients year: 1999 ident: key-10.4103/0974-7796.286327-11 publication-title: Eur J Clin Microbiol Infect Dis contributor: fullname: Gallinella – start-page: 522 volume-title: Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay year: 1986 ident: key-10.4103/0974-7796.286327-3 publication-title: J Clin Microbiol contributor: fullname: Anderson – start-page: 152 volume-title: Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: An underestimated infectious disease in the immunocompromised host year: 1997 ident: key-10.4103/0974-7796.286327-10 publication-title: J Nephrol contributor: fullname: Bertoni – start-page: 751 volume-title: Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients year: 2005 ident: key-10.4103/0974-7796.286327-15 publication-title: Clin Transplant contributor: fullname: Ki – start-page: 16 issn: 1319-2442 volume-title: The seroprevalence of parvovirus B19 among kidney transplant recipients: A single-center study year: 2014 ident: key-10.4103/0974-7796.286327-23 publication-title: Saudi J Kidney Dis Transpl contributor: fullname: Khameneh – start-page: 196 volume-title: Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients year: 2011 ident: key-10.4103/0974-7796.286327-28 publication-title: Am J Transplant contributor: fullname: Jordan – start-page: 425 volume-title: Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence year: 2002 ident: key-10.4103/0974-7796.286327-29 publication-title: Am J Transplant contributor: fullname: Barsoum – start-page: 1340 volume-title: Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection year: 2008 ident: key-10.4103/0974-7796.286327-36 publication-title: Am J Transplant contributor: fullname: Ardalan – start-page: 455 volume-title: Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients – A prospective study year: 2009 ident: key-10.4103/0974-7796.286327-19 publication-title: Transpl Int contributor: fullname: Park – start-page: 137 volume-title: Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis year: 2008 ident: key-10.4103/0974-7796.286327-18 publication-title: Exp Clin Transplant contributor: fullname: Ardalan – start-page: 664 volume-title: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia year: 1981 ident: key-10.4103/0974-7796.286327-6 publication-title: Lancet contributor: fullname: Pattison – start-page: 3211 volume-title: Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients year: 2002 ident: key-10.4103/0974-7796.286327-13 publication-title: Transplant Proc contributor: fullname: Malyszko – start-page: 87 volume-title: Effects of parvovirus B19 infection in renal transplant recipients: A retrospective review of three cases year: 2015 ident: key-10.4103/0974-7796.286327-25 publication-title: Int J Angiol contributor: fullname: Krishnan – start-page: 361 volume-title: B19 virus infection in renal transplant recipients year: 2003 ident: key-10.4103/0974-7796.286327-14 publication-title: J Clin Virol contributor: fullname: Cavallo – start-page: 1115 volume-title: Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation year: 2013 ident: key-10.4103/0974-7796.286327-22 publication-title: J Med Virol contributor: fullname: Porignaux – start-page: 72 volume-title: Parvovirus-like particles in human sera year: 1975 ident: key-10.4103/0974-7796.286327-1 publication-title: Lancet contributor: fullname: Cossart – start-page: 428 volume-title: Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes year: 2007 ident: key-10.4103/0974-7796.286327-39 publication-title: J Gen Virol contributor: fullname: Parsyan – start-page: 867 volume-title: Publication bias in clinical research year: 1991 ident: key-10.4103/0974-7796.286327-33 publication-title: Lancet contributor: fullname: Easterbrook – start-page: 201 volume-title: AST Infectious Diseases Community of Practice.Human parvovirus B19 in solid organ transplantation year: 2013 ident: key-10.4103/0974-7796.286327-2 publication-title: Am J Transplant contributor: fullname: Eid – start-page: e1000097 volume-title: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement year: 2009 ident: key-10.4103/0974-7796.286327-30 publication-title: PLoS Med contributor: fullname: Moher – start-page: 177 volume-title: Meta-analysis in clinical trials year: 1986 ident: key-10.4103/0974-7796.286327-31 publication-title: Control Clinic Trials contributor: fullname: DerSimonian – start-page: 1593 volume-title: Clinical investigation of human parvovirus B19 infection after renal transplantation in China year: 2013 ident: key-10.4103/0974-7796.286327-27 publication-title: Transplant Proc contributor: fullname: Xiao – start-page: 40 volume-title: Parvovirus B19 infection after transplantation: A review of 98 cases year: 2006 ident: key-10.4103/0974-7796.286327-16 publication-title: Clin Infect Dis contributor: fullname: Eid – start-page: S47 volume-title: Parvovirus B19 and the kidney year: 2007 ident: key-10.4103/0974-7796.286327-8 publication-title: Clin J Am Soc Nephrol contributor: fullname: Waldman – start-page: 252914 volume-title: An association between BK virus replication in bone marrow and cytopenia in kidney-transplant recipients year: 2014 ident: key-10.4103/0974-7796.286327-24 publication-title: J Transplant contributor: fullname: Pambrun – start-page: 818 volume-title: Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients year: 1997 ident: key-10.4103/0974-7796.286327-34 publication-title: Transplant Proc contributor: fullname: Bertoni – start-page: 299 volume-title: Anemia as a complication of parvovirus b19 infection in renal transplant recipients year: 2012 ident: key-10.4103/0974-7796.286327-20 publication-title: Medicina (Kaunas) contributor: fullname: Čapenko – start-page: 102829 volume-title: Parvovirus B19 infection and severe anemia in renal transplant recipients year: 2012 ident: key-10.4103/0974-7796.286327-21 publication-title: ScientificWorldJournal contributor: fullname: Carraturo – start-page: 443 volume-title: Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia year: 2013 ident: key-10.4103/0974-7796.286327-5 publication-title: J Clin Virol contributor: fullname: Plentz – start-page: 2198 volume-title: Parvovirus B19 in kidney transplant patients year: 2000 ident: key-10.4103/0974-7796.286327-12 publication-title: Transplantation contributor: fullname: Zolnourian |
SSID | ssj0066604 |
Score | 2.2735946 |
Snippet | Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of... Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and... BACKGROUNDPersistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed wolterskluwer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 241 |
SubjectTerms | Analysis Anemia Bias Blood Bone marrow Cytomegalovirus Cytotoxicity Deoxyribonucleic acid DNA Epidemiology Health aspects Immunoglobulins Infection Infections Kidney transplantation Kidney transplants Medical research Meta-analysis Original parvovirus b19 Patients renal transplantation Studies Systematic review systematic reviews Viral infections Viruses |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BDwgJId4YCixSJU6m3qez3FJI1QtcIBIXtNqniErtKE6K-u-ZXTshhkpcOPjiHVn2PHZmvDPfIHTELYvEMl5yqwwkKCSWVjhRMsujjeDyWAb1Oftcf_o6-TBLMDm7UV-pJqyHB-4ZdxyZdyRQKaKouBcJv4xZRyaGKs-CsXn3reQ2mer3YIjJ8-DASqVqw1rJvjOPk4odz6dv51M9UTqB6-z5ogzZ__fGvOeZ_qyavPOzTSfa3XkuaN9zS6f30N0hnsTT_jvuoxuheYBufRxOzB-ib7PfI2CvcBvx0qwu28vFatPhE6KwaTxcQGBwnjuEzxe-CVd4nUHPfwDfccK_WKa2ye4dnuKLsDalGaBMHqH56ezL-7NyGKlQOilEW3ouHa0C8Z7S2lfB1IRWMqhaEBeZA1cVo3TMRisp8ZaQqIiDmNIxZWoDrv0xOmjaJjxFGGQQUnuJNyZwyysbg-TSVz7WEEfVtkBHW-bqZY-coSHjSDLQIICtDAp0khi_I0lw1_kGKIEelED_SwkK9CqJTfe9ozuj1dMEKEYhq2QFepMpktkCB50Zug_gWxIA1ojycEQJ5ubGy1vV0IO5dzrlbfBmtKLXLwtGFScQDBTo9W45PThVuDWh3aRHCA65NlVVgZ70irbjCUunMDUHXtUjFRwxbbzSLL5nrPBacAm7eoHkSFn1Rd9seZ1E4FWI3irns_8hnufoNk2_KXKV8yE6WK824QW62fnNy2y2vwBI10ak priority: 102 providerName: Directory of Open Access Journals |
Title | Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis |
URI | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=3;spage=241;epage=247;aulast=Thongprayoon;type=0 https://www.ncbi.nlm.nih.gov/pubmed/33100749 https://www.proquest.com/docview/2425504202 https://www.proquest.com/docview/2532941801 https://search.proquest.com/docview/2454409290 https://pubmed.ncbi.nlm.nih.gov/PMC7546070 https://doaj.org/article/f3dc1e265f504d579953bc18a29d3eab |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6RHhASQrwxlLJIlTg58b7smFtaUvVShASRuKDVPkvUxo7yKOq_Z3Zthxh64uCLd2Sv5-GZ2Z35FqFjrpknmvGU61JBgkJ8qoURKdPcaw8uj0VQn_Ovxefv40_TAJMjul6YWLRv9HxYXS-G1fxnrK1cLsyoqxMbfbk4LQTPQVVHAzSA2LBL0ZvfL4Tj8czArAyFhkWZN015nGRsNJsMZxM5LiUJYKEsrG0XAURzzyNF4P5_f897_unv2smHv-qwr72-imXte87p7DF61EaVeNLM_gm656qn6P5Fu2_-DP2Y_jkI9hbXHi_V6qa-ma-2a3xCSqwqCxcQKBxPH8JXc1u5W7yJ0OfXwH0cUDCWoXly_RFP8MJtVKpaQJPnaHY2_XZ6nrYHK6QmF6JOLc8NzRyxltLCZk4VhGa5KwtBjGcGHJb3uWHa65wSqwnxJTEQWRpWqkKBg3-BDqq6cq8QNmTsQpOJVcpxzTPtXc5zm1lfQDRV6AQdd8yVywY_Q0LeEcQhQRadOBJ0Ehi_Iwmg1_FGvbqUreilZ9YQR3PhRcatCFB2TMMEFC0tcwre9S6ITTYdpDvTlZMAK0Yht2QJ-hApgvECB41qexDgWwIMVo_ysEcJRmf6w51qyNbo1zJkbzAzmtG7hwWjJScQEiTo_W44PDjUuVWu3oZHCA4ZNy2zBL1sFG3Hk05fE1T0VLDHtP4IGFBEDG8NJkF5T1nlomm5vEsiMBUiO-V8_d-vfIMe0LBCEQucD9HBZrV1b9FgbbdHcfnjKBrvb6IGR4w |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIgES4lnAUKiRKnFysi_bMbe0pAqirZBoJC5otU-I2thRHkX998yu7VBDTz344hnZ652ZnZn1zLcI7XPFHFGMJ1wVEhIU4hKV6jRhijvlwOWxAOoz_paffh98GnmYnLTthQlF-1pNe-XFrFdOf4XayvlM99s6sf7Xk8M85Rmoan8L3QV7xbhN0usFGALycGogLnypYV5kdVseJ5j1J8PeZCgGhSAeLpT53e3cw2he80kBuv__Bfqah_q3evLh78r_2V6eh8L2a-7p6PEtP-wJetTEo_GwJj9Fd2z5DN07af64P0c_Rn-PkL2KKxfP5eKyupwu1sv4gBSxLA1cwCDjcG5RfD41pb2KVwE0_QLkFnv8jLlvu1x-jIfxzK5kIhsolB00ORqdHY6T5kiGRGdpWiWGZ5piS4yhNDfYypxQnNkiT4l2TIOrcy7TTDmVUWIUIa4gGiSkWSFzCaHBC7RdVqV9hWJNBta3pxgpLVccK2cznhlsXA5xWK4itN8KRcxr5A0BGYsXowAZtmKM0IEX2IbFw2WHG9Xip2jmVjhmNLE0S12KuUk9CB5TMABJC8OshHfteXGLuvd0Y_Ri6AHJKGSlLEIfAoc3e5hBLZvuBfgWD6DV4dztcIK56i65VSnRLBdL4fM-GBnF9GZyymjBCQQTEXq_IfsH-wq50lZr_4iUQ65OCxyhl7WCbuak1fMI5R3V7UxalwIaGrDGG42MUNZRcjGrmzVvkggMhYhWOV_f-pV76P747ORYHH8-_fIGPaB-nyOUSe-i7dVibd-iraVZvwum_wdCaFwc |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZokSokxLsQKNRIlTilGz-SbLht210VQatKsBIXZPkJq3aT1T6K-u8ZO8mygZ7gkEs8ShzPjGfGmfkGoQOumCOK8ZirQkKAQlysUp3GTHGnHJg8FkB9Tj_n51_7J0MPk7Nu9RWS9rWaHJZX08Ny8iPkVs6mutfmifUuzo7zlGcgqr2Zcb0tdBd0NqFtoF5vwuCUh86BSeHTDfMiq0vzOElYbzw4HA9EvxDEQ4Yyf8KdeyjNDbsU4Pv_3qQ3rNSfGZT3f1b-7_biMiS3b5io0cP_-LhH6EHjl-JBTfIY3bHlE7Rz1vx5f4q-DX-3kr3BlcMzOb-urifz1QIfkQLL0sAFBBKH_kX4cmJKe4OXATz9CviHPY7GzJdfLt7jAZ7apYxlA4nyDI1Hwy_Hp3HTmiHWWZpWseGZpoklxlCam8TKnNAks0WeEu2YBpPnXKaZciqjxChCXEE0-KaaFTKX4CLsou2yKu0LhDXpW1-mYqS0XPFEOZvxzCTG5eCP5SpCBy1jxKxG4BAQuXhWCuBjy8oIHXmmrUk8bHa4Uc2_i2Z9hWNGE0uz1KUJN6kHw2MKJiBpYZiV8K59z3JR16CulV8MPDAZheiURehdoPDqDyuoZVPFAN_igbQ6lHsdSlBb3R1uxUo028ZC-PgPZkYTevtwymjBCTgVEXq7HvYP9plypa1W_hEph5idFkmEntdCul6TVtYjlHfEt7No3RGQ0oA53khlhLKOoItpXbR5G0dgKkS0wvnyn1-5j3YuTkbi04fzj6_QPeqPO0K29B7aXs5X9jXaWpjVm6D9vwAXFF6c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+parvovirus+B19+and+anemia+among+kidney+transplant+recipients%3A+A+meta-analysis&rft.jtitle=Urology+annals&rft.au=Thongprayoon%2C+Charat&rft.au=Khoury%2C+Nadeen+J&rft.au=Bathini%2C+Tarun&rft.au=Aeddula%2C+Narothama+Reddy&rft.date=2020-07-01&rft.issn=0974-7796&rft.volume=12&rft.issue=3&rft.spage=241&rft.epage=247&rft_id=info:doi/10.4103%2FUA.UA_89_19&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-7796&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-7796&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-7796&client=summon |